Last reviewed · How we verify
Calcipotriol BDP gel — Competitive Intelligence Brief
phase 3
Vitamin D3 analog / Corticosteroid combination
Vitamin D receptor (VDR); Glucocorticoid receptor
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Calcipotriol BDP gel (Calcipotriol BDP gel) — LEO Pharma. Calcipotriol is a vitamin D3 analog that binds to the vitamin D receptor to regulate skin cell differentiation and reduce inflammation in psoriasis.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Calcipotriol BDP gel TARGET | Calcipotriol BDP gel | LEO Pharma | phase 3 | Vitamin D3 analog / Corticosteroid combination | Vitamin D receptor (VDR); Glucocorticoid receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Vitamin D3 analog / Corticosteroid combination class)
- LEO Pharma · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Calcipotriol BDP gel CI watch — RSS
- Calcipotriol BDP gel CI watch — Atom
- Calcipotriol BDP gel CI watch — JSON
- Calcipotriol BDP gel alone — RSS
- Whole Vitamin D3 analog / Corticosteroid combination class — RSS
Cite this brief
Drug Landscape (2026). Calcipotriol BDP gel — Competitive Intelligence Brief. https://druglandscape.com/ci/calcipotriol-bdp-gel. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab